Last week, President Trump postponed a summit with his Chinese counterpart on account of the war with Iran. When Trump and Xi Jinping do meet, here's an agenda item bound to figure prominently: rare ...
About a decade after he bought a shuttered rare earths mine that was, literally, partially underwater, MP Materials CEO James Litinsky has transformed his business into a pivotal player in America's ...
supports efforts to reduce the economic and societal burden of rare diseases in the U.S.A. AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision ...
Spruce Biosciences has named Dale Hooks as chief commercial officer, securing a leader with experience launching 21 products as the company heads toward a filing for its first FDA approval. After ...
Federal health officials, facing criticism from lawmakers for recent rejections of rare-disease drugs, attacked an Amsterdam-based biotech company seeking approval of a Huntington’s disease treatment ...
March 5 (Reuters) - USA Rare Earth (USAR.O), opens new tab said on Thursday it would acquire the remaining minority interest in a Texas rare earth deposit in an all-stock transaction worth $73 ...
A wave of new rare-earth supply this decade won’t be enough to meet rising global demand, setting the stage for shortages and stronger pricing power for dominant supplier China and the handful of ...
For decades, the West has been sleepwalking into dependency. While we built the world’s most advanced fighter jets, smartphones, and electric vehicles, we quietly surrendered the most important ...
Marty Makary, commissioner of the Food and Drug Administration, speaks at the White House on Sept. 22. (Mark Schiefelbein/AP) Marty Makary appeared Thursday for an interview on CNBC to tout efforts ...
MP Materials has chosen Northlake, Texas, for its new $1.25 billion rare earth magnet manufacturing campus. The facility, dubbed "10X," will use rare earth raw materials that have been sourced and ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results